Open AccessSerum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China
Author(s) -
Yuan Xu,
Huan Yang,
Jing Wang,
Xiaoying Li,
Chengjun Xue,
Chunping Niu,
Pu Liao
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s312521
Subject(s) - hypoalbuminemia , medicine , albumin , transthyretin , serum albumin , comorbidity , covid-19 , biomarker , gastroenterology , clinical significance , disease , biochemistry , chemistry , infectious disease (medical specialty)
COVID-19 infections are still at pandemic levels globally and there are currently no specific drugs to treat these infections. Previous studies have demonstrated that serum albumin levels were abnormally low in COVID-19 patients and might be used as a prognosis biomarker. Supplemental albumin has been used as an experimental therapeutic method. However, dynamic evaluation of albumin in patients with COVID-19 was limited and whether serum albumin could predict the prognosis of these patients is unknown.